Virax Biolabs
VRAX
VRAX
4 hedge funds and large institutions have $22.8K invested in Virax Biolabs in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
4
Holding in Top 10
–
Calls
–
Puts
–
Top Sellers
| 1 | -$1.04M | |
| 2 | -$68.4K | |
| 3 | -$10K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$2.58K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.13K |